Silverberg Bernstein Capital Management LLC Purchases 7,507 Shares of Apyx Medical Co. (NASDAQ:APYX)

Silverberg Bernstein Capital Management LLC increased its stake in shares of Apyx Medical Co. (NASDAQ:APYXFree Report) by 1.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 621,387 shares of the company’s stock after purchasing an additional 7,507 shares during the period. Silverberg Bernstein Capital Management LLC owned approximately 1.79% of Apyx Medical worth $845,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Kingsview Wealth Management LLC acquired a new position in Apyx Medical in the fourth quarter valued at about $32,000. ProVise Management Group LLC acquired a new position in Apyx Medical in the fourth quarter valued at about $35,000. Barclays PLC acquired a new position in Apyx Medical in the third quarter valued at about $46,000. Algert Global LLC acquired a new position in Apyx Medical in the third quarter valued at about $50,000. Finally, Taylor Frigon Capital Management LLC grew its stake in Apyx Medical by 2.9% in the fourth quarter. Taylor Frigon Capital Management LLC now owns 638,965 shares of the company’s stock valued at $1,674,000 after acquiring an additional 17,818 shares during the period. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Trading Up 3.8 %

NASDAQ:APYX traded up $0.05 on Friday, reaching $1.38. The company’s stock had a trading volume of 29,906 shares, compared to its average volume of 42,223. The company has a quick ratio of 4.94, a current ratio of 5.87 and a debt-to-equity ratio of 1.64. The business’s 50-day moving average price is $1.48 and its two-hundred day moving average price is $1.89. Apyx Medical Co. has a 1-year low of $1.21 and a 1-year high of $7.97.

Apyx Medical (NASDAQ:APYXGet Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.04). The firm had revenue of $10.24 million for the quarter, compared to analyst estimates of $9.64 million. Apyx Medical had a negative return on equity of 76.16% and a negative net margin of 45.20%. During the same period in the prior year, the company earned ($0.10) earnings per share. As a group, equities analysts forecast that Apyx Medical Co. will post -0.75 earnings per share for the current year.

Apyx Medical Profile

(Free Report)

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.

Read More

Want to see what other hedge funds are holding APYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apyx Medical Co. (NASDAQ:APYXFree Report).

Institutional Ownership by Quarter for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.